Deciding on genetic testing for familial dementia: Perspectives of patients and families

Half of memory clinic patients' who met eligibility criteria proceeded with genetic testing. Those tested were more likely to have an undetermined diagnosis, better cognition, and higher quality of life. Decisions were motivated less by deliberation of factual information, and more by quick, intuitive judgments. Motivations pro included providing information, enhancing actionability, and resolving uncertainty. Motivations con comprised concerns about the emotional burden and disruptive impact on their family.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-04-01
DOI
https://doi.org/10.1002/alz.70140
Citations
2
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
3.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deciding on genetic testing for familial dementia: Perspectives of patients and families

Eva C. A. Asscher, Leonie N.C. Visser, Wiesje M. van der Flier, Annelien L. Bredenoord et al.
2 citations
Alzheimer s & Dementia
Genomics and Rare Diseases
3.63
article

Deciding on genetic testing for familial dementia: Perspectives of patients and families

Eva C. A. Asscher, Leonie N.C. Visser, Wiesje M. van der Flier, Annelien L. Bredenoord, Sven J. van der Lee, Christa M. de Geus, Jetske van der Schaar, Mariëtte van den Hoven, Ellen M.A. Smets, Yolande A.L. Pijnenburg
article en
2 citations

Abstract

Half of memory clinic patients' who met eligibility criteria proceeded with genetic testing. Those tested were more likely to have an undetermined diagnosis, better cognition, and higher quality of life. Decisions were motivated less by deliberation of factual information, and more by quick, intuitive judgments. Motivations pro included providing information, enhancing actionability, and resolving uncertainty. Motivations con comprised concerns about the emotional burden and disruptive impact on their family.

Alzheimer s & DementiaVol. 21(4)
Utrecht University (NL), University Medical Center Utrecht (NL), Amsterdam Neuroscience (NL), GGD Amsterdam (NL), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), Erasmus University Rotterdam (NL)
ZonMw, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Stichting Dioraphte, Alzheimer Nederland, Amsterdam Neuroscience
Openalex Percentile: Top 9%
Genomics and Rare Diseases
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Deciding on genetic testing for familial dementia: Perspectives of patients and families — Eva C. A. Asscher, Leonie N.C. Visser, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS